This study aimed to evaluate the use of ozone to treat recurrent aphthous stomatitis (RAS). Consecutive sixty-nine participants with RAS were recruited into this non-randomized double blind, controlled cohort observational study (test group). A control group of 69 RAS patients who matched test group with age and gender was recruited. RAS lesions in test group were exposed to ozone in air for 60 seconds while controls received only air. Ulcer size and pain were recorded for each participant at baseline and daily for 15 days. Ulcer duration was determined by recording the time taken for ulcers to disappear. The main outcome measures were pain due to the ulcer, ulcer size and ulcer duration. 138 RAS participants (69 participants and 69 control...
Background: ozone therapy has been successfully used in the treatment of pulpitis, periodontitis, ap...
Introduction: The bacterium Staphylococcus aureus is, in most cases, the agent of the disease. Thus,...
Ozone, an antibacterial, has a spectrum of action which is bigger than any antibiotic known today. V...
This article is included with the publisher's permission. More information about the journal can be ...
The underlying etiology of recurrent aphthous stomatitis (RAS) is unclear and treatment aims to prov...
Faculty of Medicine and Pharmacy, Galati, Romania, The 6th International Medical Congress for Studen...
Today, dentists face a diffcult task: in conditions of unfavorable environmental conditions, increas...
Chemotherapy usually causes complications affecting several tissues such as oral mucosa. In this cas...
Background: Cancer is the second leading cause of death in the world after heart disease. One type o...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not laser therapy i...
Aim Recurrent aphthous stomatitis (RAS) is a painful and common ulcerative form that can pose a diag...
Background: Recurrent aphthous stomatitis (RAS) is the most common painful ulcers of oral mucosal wh...
BACKGROUND: Recurrent Aphthous Ulcer (RAU) or Recurrent Aphthous Stomatitis (RAS) is one of the co...
Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity, affecting...
The aim of this systematic review was to assess a potential benefit of laser use in the treatment of...
Background: ozone therapy has been successfully used in the treatment of pulpitis, periodontitis, ap...
Introduction: The bacterium Staphylococcus aureus is, in most cases, the agent of the disease. Thus,...
Ozone, an antibacterial, has a spectrum of action which is bigger than any antibiotic known today. V...
This article is included with the publisher's permission. More information about the journal can be ...
The underlying etiology of recurrent aphthous stomatitis (RAS) is unclear and treatment aims to prov...
Faculty of Medicine and Pharmacy, Galati, Romania, The 6th International Medical Congress for Studen...
Today, dentists face a diffcult task: in conditions of unfavorable environmental conditions, increas...
Chemotherapy usually causes complications affecting several tissues such as oral mucosa. In this cas...
Background: Cancer is the second leading cause of death in the world after heart disease. One type o...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not laser therapy i...
Aim Recurrent aphthous stomatitis (RAS) is a painful and common ulcerative form that can pose a diag...
Background: Recurrent aphthous stomatitis (RAS) is the most common painful ulcers of oral mucosal wh...
BACKGROUND: Recurrent Aphthous Ulcer (RAU) or Recurrent Aphthous Stomatitis (RAS) is one of the co...
Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity, affecting...
The aim of this systematic review was to assess a potential benefit of laser use in the treatment of...
Background: ozone therapy has been successfully used in the treatment of pulpitis, periodontitis, ap...
Introduction: The bacterium Staphylococcus aureus is, in most cases, the agent of the disease. Thus,...
Ozone, an antibacterial, has a spectrum of action which is bigger than any antibiotic known today. V...